Skip to main content

Advertisement

SpringerLink
Log in

Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu) necessitate a full colonic visualization?

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background

Hereditary hemorrhagic telangiectasia (HHT) (the Osler–Weber–Rendu syndrome) is a rare autosomal dominant disease characterized by telangiectasias and arteriovenous malformations of the upper and lower respiratory tract, gastrointestinal tract, skin and central nervous system. Several previous reports have documented the appearance of a concomitant neoplasm in patients with this syndrome.

Aims

To study the occurrence and the clinical characterization of colonic neoplasm in patients with HHT.

Methods

We retrospectively reviewed the computerized database of the Hadassah University Hospitals (Jerusalem, Israel) for all patients with the diagnosis of HHT between January 1st, 1980 and July 30th, 2002. Cases of neoplasm were documented by review of medical charts and pathology reports.

Results

Six of the 24 patients developed malignancy. Three of the cases had extra colonic malignancy (melanoma in two patients and adenocarcinoma of urinary bladder in one patient) and three patients had adenocarcinoma of the colon. An additional three patients developed multiple colonic polyps (one patient had melanoma and one patient had adenocarcinoma of urinary bladder).

Conclusions

HHT may be associated with the development of colonic adenocarcinoma and polyps. Therefore, in patients with HHT who present with new-onset anemia or gastrointestinal bleeding a lower gastrointestinal tract evaluation should be performed, even if their blood loss is suspected to be a manifestation of gastrointestinal HHT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Guttmacher AE, Marchuk DA, White RI (1995) Hereditary hemorrhagic telangiectasia—review. N Engl J Med 333:918–924

    CAS  PubMed  Google Scholar 

  2. Shovlin CL, Letarte M (1999) Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54:714–729

    CAS  PubMed  Google Scholar 

  3. McAllister KA, Grogg KM, Johnson DW et al (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet 8:345–351

    CAS  PubMed  Google Scholar 

  4. Johnson DW, Berg JN, Baldwin MA et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13:189–195

    CAS  PubMed  Google Scholar 

  5. Piantanida M, Buscarini E, Dellavecchia C et al (1996) Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. Med Genet 33:441–443

    CAS  PubMed  Google Scholar 

  6. Wallace GMF, Shovlin CL (2000) A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax 55:685–690

    Article  CAS  PubMed  Google Scholar 

  7. Jameson CF (1989) Primary hepatocellular carcinoma in hereditary haemorrhagic telangiectasia: a case report and literature review. Histopathology 15:550–551

    CAS  PubMed  Google Scholar 

  8. Sussman EB, Stephen MD, Sternberg MD (1975) Hereditary hemorrhagic telangiectasia—a case with hepatocellular carcinoma and acquired hepatocerebral degeneration. Arch Pathol 99:95–100

    CAS  PubMed  Google Scholar 

  9. Breuninger H, Bogenschurz O, Konrad E et al (1997) Teleangiectasia haemorrhagica hereditaria (Osler–Weber–Rendu disease). Surgical therapy of malignant skin tumors. Hautarzt 48:496–499

    Article  CAS  PubMed  Google Scholar 

  10. Kato S, Ichiara K (1988) Hereditary hemorrhagic telangiectasia with malignant lymphoma. An autopsy case. Acta Pathol Jpn 38:383–391

    CAS  PubMed  Google Scholar 

  11. Livandovskii IuA, Listratov Sia, Naumova GA (1975) Rare case of association of Rendu–Osler disease with lymphocytic leukemia. Klin Med (Mosk) 53:118–119

    Google Scholar 

  12. Patakfalvi A, Marton E (1974) Simultaneous occurrence of Osler–Weber disease and IgA myeloma with severe antibody deficiency syndrome. Orv Hetil 115:1287–1289

    CAS  PubMed  Google Scholar 

  13. Gemke GR, Kaupasa MM, Rafalskii AA et al (1994) Association of Rendu–Osler disease, polyarthritis and ovarian cancer. Klin Med (Mosk) 72:65–66

    Google Scholar 

  14. Goldman K, De Pietro WP (1989) A case of adenocarcinoma of the colon in a patient with hereditary hemorrhagic telangiectasis. Cutis 43:371–372

    CAS  PubMed  Google Scholar 

  15. Hisamura M, Akita K, Ide H (1994) A case of Rendu–Osler–Weber disease associated with simultaneous, multiple advanced cancers in the colon. Hokkaido Igaku Zasshi 69:1468–1475

    CAS  PubMed  Google Scholar 

  16. Conte WJ, Rotter JI, Schwartz AG et al (1982) Hereditary generalized juvenile polyposis, arteriovenous malformations and colonic carcinoma (Abstract). Clin Res 30:93A

    Google Scholar 

  17. Baert AL, Casteels-Van Daele M, Broeckx J et al (1983) Generalized juvenile polyposis with pulmonary arteriovenous malformations and hypertrophic osteoarthropathy. Am J Roentgenol 141:661–662

    CAS  Google Scholar 

  18. Cox KL, Frates RC, Wong A et al (1980) Hereditary generalized juvenile polyposis associated with pulmonary arteriovenous malformation. Gastroenterology 78:1566–1570

    CAS  PubMed  Google Scholar 

  19. Radin DR (1994) Hereditary generalized juvenile polyposis: association with arteriovenous malformations and risk of malignancy. Abdom Imaging 19:140–142

    CAS  PubMed  Google Scholar 

  20. Prieto G, Polanco JS, Larrauri J et al (1990) Association of juvenile adenomatous polyposis with pulmonary arteriovenous malformation and hypertrophic osteoarthropathy. J Pediatr Gastroenterol Nutr 11:133–137

    CAS  PubMed  Google Scholar 

  21. Gillespie JS, McIvor RA (2001) Hereditary hemorrhagic telangiectasia in association with generalized juvenile polyposis. Ulster Med J 70:145–148

    CAS  PubMed  Google Scholar 

  22. Ballauff A, Koletzko S (1999) Hereditary hemorrhagic telangiectasia with juvenile polyposis-coincidence or linked autosomal dominant inheritance? Z Gastroenterol 37:385–388

    CAS  PubMed  Google Scholar 

  23. Schumacher B, Frieling T, Borchard F et al (1994) Hereditary hemorrhagic telangiectasia associated with multiple pulmonary arteriovenous malformations and juvenile polyposis. Z Gastroenterol 32:105–108

    CAS  PubMed  Google Scholar 

  24. Inoue S, Matsumoto T, Iida M et al (1999) Juvenile polyposis occurring in hereditary hemorrhagic telangiectasia. Am J Med Sci 317:59–62

    Article  CAS  PubMed  Google Scholar 

  25. Boardman LA, Thibodeau SN, Schaid DJ et al (1998) Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 128:896–899

    CAS  PubMed  Google Scholar 

  26. Giardiello FM, Welsh SB, Hamilton SR et al (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316:1511–1514

    CAS  PubMed  Google Scholar 

  27. Lynch HT, Smyrk T, Lynch J (1996) Hereditary non-polyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 78:1149–1167

    Article  CAS  PubMed  Google Scholar 

  28. Gilchrist DM (1997) Hereditary colon cancer. Can J Gastroenterol 11:421–423

    CAS  PubMed  Google Scholar 

  29. Coburn MC, Pricolo VE, DeLuca FG et al (1995) Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 2:385–391

    Google Scholar 

  30. Plauchu H, De Chadarevian JP, Bideau A et al (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32:291–297

    CAS  PubMed  Google Scholar 

  31. SEER Program (1999) SEER cancer statistics review: 1990–1999. National Cancer Institute, Bethesda, MD. Seer cancer.gov

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Mount Scopus Hadassah Hospital, P.O. Box 24035, Jerusalem 91240, Israel

    Eran Elinav, Shaden Salameh-Giryes, Zvi Ackerman, Neta Goldschmidt, Aviram Nissan & Tova Chajek-Shaul

Authors
  1. Eran Elinav
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaden Salameh-Giryes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zvi Ackerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Neta Goldschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aviram Nissan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tova Chajek-Shaul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tova Chajek-Shaul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elinav, E., Salameh-Giryes, S., Ackerman, Z. et al. Does any lower gastrointestinal bleeding in patients suffering from hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu) necessitate a full colonic visualization?. Int J Colorectal Dis 19, 595–598 (2004). https://doi.org/10.1007/s00384-004-0607-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-004-0607-3

Keywords

Search

Navigation